{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:33:47Z","timestamp":1787762027337,"version":"build-2784847793"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Mucormycosis is a fatal fungal infection, which is rare but commonly affects immunocompromised patients. Coronavirus disease 2019 (COVID-19) patients who were immunocompromised, due to comorbid conditions, such as hematological malignancy and diabetes mellitus (DM), and patients on immunosuppressive therapy such as steroid therapy were the important host for mucormycosis infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>This study aimed to study the clinicopathological correlation of mucormycosis in post-COVID-19 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Methods:<\/jats:title>\n                    <jats:p>The study was a retrospective study conducted in the Department of Pathology, Sarojini Naidu Medical College, Agra, Uttar Pradesh, India, over four months from April 2021 to July 2021, and clinically diagnosed mucormycosis cases were included in this study. Clinical details, histology slides, and blocks were reviewed, and the data were analyzed. Three- to four-micrometer sections were taken from the blocks and stained with hematoxylin and eosin, and two more slides were made for each case for periodic acid\u2013Schiff (PAS) and Grocott methenamine silver (GMS) staining.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result:<\/jats:title>\n                    <jats:p>In this study, the maximum cases were above the fifth decade of life. Males were more commonly affected than females with a male-to-female ratio of 2.09:1. Of the total of 65 cases, 46 (70.77%) cases were positive for mucormycosis and 19 (29.23%) cases were negative on histopathological examination and special stain PAS and GMS. A significant correlation was found between mucormycosis-positive cases on steroid therapy and oxygen supply during the treatment for COVID-19 with P- values of 0.001 and 0.027, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>For COVID-19 patients with altered glycemic control, receiving steroid therapy and oxygen supply poses a significant threat to the development of mucormycosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njms.njms_482_21","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T08:07:23Z","timestamp":1689235643000},"page":"264-270","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathological profile of post-COVID-19 mucormycosis cases: A report from a tertiary care center"],"prefix":"10.4103","volume":"14","author":[{"given":"Nupur","family":"Kaushik","sequence":"first","affiliation":[{"name":"Department of Pathology, S.N. Medical College Agra, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Rani","sequence":"additional","affiliation":[{"name":"Department of Pathology, S.N. Medical College Agra, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Pathology, S.N. Medical College Agra, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harendra","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pathology, S.N. Medical College Agra, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pathology, S.N. Medical College Agra, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhil Pratap","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of ENT, S.N. Medical College Agra, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"key":"R1-20240908","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19:A systematic review of cases reported worldwide and in India","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"R2-20240908","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF01932420","article-title":"Mycosis mucorina","volume":"102","author":"Paltauf","year":"1885","journal-title":"Arch Pathol Anat"},{"key":"R3-20240908","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/jama.1957.02970450007003","article-title":"Mucormycosis;A new disease?","volume":"163","author":"Baker","year":"1957","journal-title":"J Am Med Assoc"},{"key":"R4-20240908","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1439-0507.2001.00656.x","article-title":"Mucormycoses","volume":"44","author":"Eucker","year":"2001","journal-title":"Mycoses"},{"key":"R6-20240908","doi-asserted-by":"crossref","first-page":"67","DOI":"10.18231\/j.ijirm.2021.015","article-title":"Mucormycosis in COVID-19- A burgeoning epidemic in the ongoing pandemic","volume":"6","author":"Yadav","year":"2021","journal-title":"IP Indian J Immunol Respir Med"},{"key":"R9-20240908","first-page":"e10726","article-title":"Rhino-orbital mucormycosis associated with COVID-19","volume":"12","author":"Mehta","year":"2020","journal-title":"Cureus"},{"key":"R10-20240908","doi-asserted-by":"crossref","first-page":"n1238","DOI":"10.1136\/bmj.n1238","article-title":"Covid-19:India sees record deaths as \u201cblack fungus\u201dspreads fear","volume":"373","author":"Dyer","year":"2021","journal-title":"BMJ"},{"key":"R11-20240908","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s43055-021-00535-9","article-title":"Rhino-orbital mucormycosis in COVID-19 patients-A new threat?","volume":"52","author":"Awal","year":"2021","journal-title":"Egypt J Radiol Nucl Med"},{"key":"R12-20240908","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/CMR.18.3.556-569.2005","article-title":"Novel perspectives on mucormycosis:Pathophysiology, presentation, and management","volume":"18","author":"Spellberg","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"R13-20240908","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/CMR.13.2.236","article-title":"Zygomycetes in human disease","volume":"13","author":"Ribes","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"R14-20240908","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1172\/JCI111395","article-title":"Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus","volume":"74","author":"Waldorf","year":"1984","journal-title":"J Clin Invest"},{"key":"R15-20240908","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1128\/iai.38.3.1123-1129.1982","article-title":"Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum:Relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis","volume":"38","author":"Chinn","year":"1982","journal-title":"Infect Immun"},{"key":"R16-20240908","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/ki.1994.89","article-title":"Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect","volume":"45","author":"Boelaert","year":"1994","journal-title":"Kidney Int"},{"key":"R17-20240908","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2337\/diacare.31.12.1109","article-title":"A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis:Transferrin and iron availability","volume":"31","author":"Artis","year":"1982","journal-title":"Diabetes"},{"key":"R18-20240908","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1017\/S0022215121000992","article-title":"Post coronavirus disease mucormycosis:A deadly addition to the pandemic spectrum","volume":"135","author":"Sharma","year":"2021","journal-title":"J Laryngol Otol"},{"key":"R19-20240908","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s12663-021-01532-1","article-title":"SARS-CoV-2, uncontrolled diabetes and corticosteroids-an unholy trinity in invasive fungal infections of the maxillofacial region?A retrospective, multi-centric analysis","volume":"20","author":"Moorthy","year":"2021","journal-title":"J Maxillofac Oral Surg"},{"key":"R20-20240908","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4103\/ijo.IJO_3763_20","article-title":"COVID-19 and orbital mucormycosis","volume":"69","author":"Sarkar","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"R21-20240908","doi-asserted-by":"crossref","first-page":"867","DOI":"10.18203\/issn.2454-5929.ijohns20211583","article-title":"A case series of invasive mucormycosis in patients with COVID-19 infection","volume":"7","author":"Mishra","year":"2021","journal-title":"Int J Otorhinolaryngol Head Neck Surg"},{"key":"R22-20240908","doi-asserted-by":"crossref","first-page":"815","DOI":"10.18203\/issn.2454-5929.ijohns20211574","article-title":"Mucormycosis coinfection associated with global COVID-19:A case series from India","volume":"7","author":"Satish","year":"2021","journal-title":"Int J Otorhinolaryngol Head Neck Surg"}],"container-title":["National Journal of Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njms.njms_482_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:14:26Z","timestamp":1787760866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njms.njms_482_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/njms.njms_482_21","relation":{},"ISSN":["0975-5950","2229-3418"],"issn-type":[{"value":"0975-5950","type":"print"},{"value":"2229-3418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"2021-10-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}